Table 3.

Cardiovascular health benefits of sulforaphane: evidence from animal studies.

Effects	Animal Species	Treatment Doses	Duration	Results	References
Cardiovascular health benefits	ICR strain mice	0.125–0.5 mg/kg iv	Single dose	Inhibited platelet aggregation	Jayakumar et al. (2013) [60]
	C57BL/6N mice	50 µg/kg ip	3 days	Increased cardiac function Increased cardiomyocyte survival	Zhang et al. (2022) [61]
	MI model rats	5 mg/kg ip	25 days	Cardioprotective effects from ischemia	Poletto Bonetto et al. (2022) [59]
	Sprague Dawley rats	0.5 mg/kg sc	6 weeks	Prevented fibrosis and cardiac hypertrophy caused by doxorubicin	Bai et al. (2017) [62]